PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-May-2026 UFP Technologies Announces Strong Q1 Results Businesswire
04-May-2026 Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
04-May-2026 Travere Therapeutics Reports First Quarter 2026 Financial Results Businesswire
04-May-2026 Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 2026 Businesswire
04-May-2026 Printing the Future of Medicine: CTIBIOTECH™ Announces $27 Million Investment to Launch U.S. Operations at the SelectUSA Investment Summit Businesswire
04-May-2026 Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use Businesswire
04-May-2026 Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders ACCESS Newswire
04-May-2026 Lannett Company, Lanexa Biologics and Sunshine Lake Pharma announce FDA Approval of LANGLARA™ an Interchangeable Biosimilar of Lantus® (insulin glargine) Businesswire
04-May-2026 Precision Digital Health Appoints Connie Pearcy as Chief Executive Officer Businesswire
04-May-2026 Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering Businesswire
04-May-2026 Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland ACCESS Newswire
04-May-2026 Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing Businesswire
04-May-2026 Schrödinger to Participate in Upcoming Investor Conferences Businesswire
04-May-2026 Ardena Strengthens Executive Team to Drive its Next Phase of Growth Ardena
04-May-2026 Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations Businesswire
04-May-2026 Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics Businesswire
04-May-2026 OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 Businesswire
04-May-2026 Rejoni Appoints Women’s Health MedTech Leader John Nealon as Chief Executive Officer Businesswire
04-May-2026 Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID) Businesswire
04-May-2026 Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time Businesswire